PharmaSGP Holding SE - ESG Rating & Company Profile powered by AI
Browse to the end of the page for potential risks for PharmaSGP Holding SE based on industry, location and marketcap. If you are employed by PharmaSGP Holding SE and you wish to licence your Sustainability rating, please contact us. The ESG assessment for PharmaSGP Holding SE represents the company's transparency towards the UN SDGs.
PharmaSGP Holding SE in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.3; made up of an environmental score of 3.2, social score of 4.8 and governance score of 8.0.
5.3
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 645 | Biomm SA | 5.4 | High |
| 645 | Tiziana Life Sciences PLC | 5.4 | High |
| 658 | PharmaSGP Holding SE | 5.3 | High |
| 658 | Cellmid Ltd | 5.3 | High |
| 658 | Bio-Techne Corp | 5.3 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does PharmaSGP Holding SE have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes PharmaSGP Holding SE disclose current and historical energy intensity?
Sign up for free to unlockDoes PharmaSGP Holding SE report the average age of the workforce?
Sign up for free to unlockDoes PharmaSGP Holding SE reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes PharmaSGP Holding SE disclose its ethnicity pay gap?
Sign up for free to unlockDoes PharmaSGP Holding SE disclose cybersecurity risks?
Sign up for free to unlockDoes PharmaSGP Holding SE offer flexible work?
Sign up for free to unlockDoes PharmaSGP Holding SE have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes PharmaSGP Holding SE disclose the number of employees in R&D functions?
Sign up for free to unlockDoes PharmaSGP Holding SE conduct supply chain audits?
Sign up for free to unlockDoes PharmaSGP Holding SE disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes PharmaSGP Holding SE conduct 360 degree staff reviews?
Sign up for free to unlockDoes PharmaSGP Holding SE disclose the individual responsible for D&I?
Sign up for free to unlockDoes PharmaSGP Holding SE disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes PharmaSGP Holding SE disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes PharmaSGP Holding SE disclose water use targets?
Sign up for free to unlockDoes PharmaSGP Holding SE have careers partnerships with academic institutions?
Sign up for free to unlockDid PharmaSGP Holding SE have a product recall in the last two years?
Sign up for free to unlockDoes PharmaSGP Holding SE disclose incidents of discrimination?
Sign up for free to unlockDoes PharmaSGP Holding SE allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas PharmaSGP Holding SE issued a profit warning in the past 24 months?
Sign up for free to unlockDoes PharmaSGP Holding SE disclose parental leave metrics?
Sign up for free to unlockDoes PharmaSGP Holding SE disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes PharmaSGP Holding SE disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes PharmaSGP Holding SE disclose the pay ratio of women to men?
Sign up for free to unlockDoes PharmaSGP Holding SE support suppliers with sustainability related research and development?
Sign up for free to unlockDoes PharmaSGP Holding SE disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes PharmaSGP Holding SE reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs PharmaSGP Holding SE involved in embryonic stem cell research?
Sign up for free to unlockDoes PharmaSGP Holding SE disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes PharmaSGP Holding SE disclose its waste policy?
Sign up for free to unlockDoes PharmaSGP Holding SE report according to TCFD requirements?
Sign up for free to unlockDoes PharmaSGP Holding SE disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes PharmaSGP Holding SE disclose energy use targets?
Sign up for free to unlockDoes PharmaSGP Holding SE disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes PharmaSGP Holding SE have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for PharmaSGP Holding SE
These potential risks are based on the size, segment and geographies of the company.
PharmaSGP Holding SE manufactures over-the-counter drugs, and other healthcare products in Germany. The company's pharmaceutical products include Baldriparan for the treatment of sleep disorders; Spalt, Formigran, and Kamol massage cream for the treatment of different pain conditions; RubaXX pharmaceutical drops for the treatment of rheumatic pain in bones, tendons, and muscles; Restaxil pharmaceutical drops for the treatment of nerve pain in neck and back; Fulminan, a beauty drink for problems in areas, such as eye area, buttocks, or thighs; DESEO pharmaceutical drops for sexual weakness; Neradin, a drug for sexual dysfunction; and TAUMEA, a drug for the treatment of vertigo. It also offers products for the treatment of chronic indications, including pain and other age-related ailments. The company sells its products through pharmacies and wholesalers. It exports its products to European countries comprising Austria, Italy, Belgium, Spain, and France. The company was founded in 2012 and is based in Gräfelfing, Germany.